High
$14.62
Open
$14.18
Market Cap
9.25B
52W High
$90.97
Low
$13.75
P. Close
$14.45
P/E
9.17
52W Low
$11.74
Fwd P/E
12.37
DailyIQ Est.
$17.49
Inst. Ownership
53.7%
Short Interest
3.26%
Days to Cover
4.1
Technical Score (1D)
14
BEARISH
News Sentiment
69
BULLISH
On Oct 7, KeyBanc upgraded Corteva (CTVA) to an overweight rating from sector weight and raised its price target to $17, reflecting confidence in the company’s earnings and market share growth. On Oct 6, JPMorgan also upgraded CTVA to overweight, setting a $19 price target and noting the company’s spin‑off of its advanced seed and genetics unit as a catalyst for renewed focus on crop protection. That same day, CTVA was added to the S&P MidCap 400 following the spin‑off, and the stock closed up 12.27%, with trading volume surging to 38.9 million shares, about 285 % above its three‑month average. The upgrades and index inclusion were reported as strong endorsements of Corteva’s standalone prospects and were seen as likely to support its valuation moving forward. Earlier, on Oct 1, Corteva shares had fallen roughly 84 % after a court cleared the Vylor spin‑off, which transferred the seed business to a new company and reduced Corteva’s asset base and shareholder value. The October 6 upgrades and the October 7 KeyBanc rating change both highlighted analysts’ positive sentiment toward Corteva’s post‑spin‑off strategy.
CTVA|Analyst Targets
CTVA|Analyst Targets
LOW TARGET
$14 -5.9%
2 analysts
MEAN TARGET
$17 +17.1%
16 analysts
HIGH TARGET
$20 +37.9%
13 analysts
PRICE RANGE
$13.65 - $20.00
SB / B / H / S / SS
7/13/9/1/1
DAILYIQ EST.
$17.49 (+20.6%)
CTVA|Company Info
CTVA|Company Info
Sector
Basic Materials
Industry
Agricultural Inputs
Exchange
NYQ
Country
United States
Website
Symbol
CTVA
Description
Corteva, Inc. is a global agricultural company focused on providing farmers with innovative solutions for crop production. The company operates through two primary segments: Seed and Crop Protection. Its Seed segment develops and supplies advanced seed genetics and traits designed to optimize crop yields and enhance resistance to environmental challenges and pests. The Crop Protection segment offers a portfolio of herbicides, insecticides, and other products that protect crops from various threats, while also promoting plant health. Corteva's products and services are utilized across the agricultural input industry, with a global presence spanning North and South America, Europe, Asia Pacific, and Africa. The company, headquartered in Indianapolis, Indiana, was established in 2018.
CTVA|Insider Trading
CTVA|Insider Trading
Bought (1Y)
0 shares
$0
Sold (1Y)
8,963 shares
$727K
KISSAM LUTHER C IVChief Executive Officer
TITUS BRIANSee Remarks
TITUS BRIANSee Remarks
TITUS BRIANSee Remarks
TITUS BRIANSee Remarks
CTVA|Fundamentals
CTVA|Fundamentals
Bullish
Overall: Bullish
Revenue growing year over year
Positive net margin
Positive operating cash flow
Net Margin
6.3%
Net income as a share of revenue: what's left for shareholders after every expense.
Revenue CAGR
2.9%
Compound annual growth rate of revenue across the fiscal years on file.
Current Ratio
1.43x
Current assets divided by current liabilities: the ability to cover obligations due within a year. Above 1.5x is comfortable, below 1x is a warning sign.
Debt / Equity
0.10x
Total interest-bearing debt divided by shareholder equity: how leveraged the balance sheet is.
Return on Equity
4.5%
Net income divided by shareholder equity: how efficiently the company turns equity capital into profit.
CTVA|Earnings Snapshot
CTVA|Earnings Snapshot
Earnings Summary
Corteva, Inc. is a global agricultural company focused on providing farmers with innovative solutions for crop production, operating through Seed and Crop Protection segments. The company serves the agricultural inputs sector, delivering advanced seed genetics and a portfolio of herbicides, insecticides, and plant health products worldwide. In the most recent quarter, Q1 2026, Corteva reported earnings per share of $1.50, surpassing the $1.18 estimate, and revenue of $4.905 billion, exceeding the $4.637 billion forecast, marking a 5.5% revenue increase from Q4 2025 and a 13% EPS acceleration. The preceding quarter, Q4 2025, saw EPS of $0.22 against a $1.175 estimate and revenue of $3.91 billion versus a $4.643 billion estimate, indicating a significant revenue shortfall and a sharp EPS miss. Over the last four quarters, Corteva has posted EPS beats in three of the four periods, with revenue growth accelerating from $3.98 billion in Q4 2024 to $6.456 billion in Q2 2025, before a sharp decline in Q3 2025 and a rebound in Q1 2026. Historically, the company has maintained a YoY revenue growth trajectory of roughly 10–15% in the first half of 2025, while EPS has fluctuated, with notable misses in Q4 2025 and Q3 2025 but consistent beats in the first two quarters of 2025. Recent news highlights Corteva’s spin‑off of its seed business into Vylor, a move that has prompted a significant stock price decline and a lawsuit potentially reversing the split, adding legal uncertainty.
EPS
EstBeatMiss
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.18 | - | - |
| Q2'26 | $2.23 | $2.30 | +2.9% |
| Q1'26 | $1.18 | $1.50 | +27.1% |
| Q4'25 | $1.17 | $0.22 | -81.3% |
| Q3'25 | $-0.47 | $-0.23 | +50.6% |
| Q2'25 | $1.88 | $2.20 | +17.1% |
Revenue
EstBeatMiss
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.9B | - | - |
| Q2'26 | $6.7B | $6.4B | -5.0% |
| Q1'26 | $4.6B | $4.9B | +5.8% |
| Q4'25 | $4.6B | $3.9B | -15.8% |
| Q3'25 | - | - | - |
| Q2'25 | - | $6.5B | - |
CTVA|Monthly Returns
CTVA|Monthly Returns
Market Data
CTVA Stock Snapshot
$14.50+$0.05 (0.3%)
- Market cap
- 9.25B
- P/E ratio
- 9.2
- Day range
- $13.75 – $14.62
- News sentiment
- 69/100 · Bullish
- Analyst target
- $16.98 (+17.1%)
- Consensus
- Buy · 31 analysts
52-week range+23.5% off low · -84.1% from high
$11.74$90.97
Price $14.50 DailyIQ Est. $17.49
CTVA's technical picture is under pressure, with momentum working against price. At this size, a single catalyst moves the stock further than it would a larger peer.
Sector Rotation
Is money rotating into or out of CTVA's sector?
Corteva, Inc. sits in the Materials sector, currently ranked 10th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #10 of 12
- Sector state
- Improving
- Sector rotation score
- 18
Analyst Rating Changes
Are analysts turning bullish or bearish on CTVA?
Keybanc most recently upgraded Corteva, Inc. to Overweight on Oct 7, 2026 with a price target of $17. Over the last 90 days, coverage has run 2 upgrades against 0 downgrades, a net bullish lean.
- Latest action
- Keybanc — Overweight
- 90-day upgrades
- 2
- 90-day downgrades
- 0
- Net rating momentum
- +2
CTVA Competitive Positioning
Corteva, Inc. (CTVA) is tracked alongside these names in Agricultural Inputs on DailyIQ — ranked by market cap, with today's move alongside.
- CTVAyou're hereCorteva, Inc.$9.3B+0.35%
- CFCF Industries Holdings, Inc.$17.6B+0.66%
- MOSThe Mosaic Company$6.7B+0.35%
- FMCFMC Corporation$1.4B+0.22%
Held by These ETFs
CTVA is a top holding in these ETFs tracked on DailyIQ — bar length shows portfolio weight.
News Sentiment Analysis
Sentiment gathered from recent headlines
69/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
10+ articles
Technical Analysis
Real-time indicators across multiple timeframes
14
BEARISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Institutional & Hedge Fund Ownership
25 tracked managers · $27.24B combined position · 12 adding, 11 trimming, 2 unchanged (latest 13F filings)
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 80,536,951 | 12.68% | $5.40B | 2026-01-29 |
| BlackRock, Inc. | ▼ Sell | 53,845,550 | 8.48% | $4.56B | 2026-08-07 |
| Capital World Investors | ▲ Buy | 42,923,729 | 6.76% | $3.64B | 2026-08-12 |
| FMR LLC (Fidelity) | ▲ Buy | 41,072,288 | 6.47% | $3.48B | 2026-08-13 |
| Geode Capital Management, LLC | ▲ Buy | 18,899,903 | 2.98% | $1.59B | 2026-08-12 |
| Harris Associates L P | ▼ Sell | 16,333,110 | 2.57% | $1.38B | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 12,066,415 | 1.90% | $1.02B | 2026-08-13 |
| Invesco Ltd. | ▼ Sell | 9,526,145 | 1.50% | $806.77M | 2026-08-14 |
| Morgan Stanley | ▼ Sell | 7,993,002 | 1.26% | $676.93M | 2026-08-13 |
| Wellington Management Group LLP | ▲ Buy | 7,612,704 | 1.20% | $644.72M | 2026-08-14 |
| Janus Henderson Group plc | • Hold | 7,254,186 | 1.14% | $607.25M | 2026-05-18 |
| Goldman Sachs Group Inc | ▲ Buy | 7,111,959 | 1.12% | $602.31M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 6,423,177 | 1.01% | $535.50M | 2026-08-12 |
| Bank of America Corp | ▲ Buy | 5,725,909 | 0.90% | $484.93M | 2026-08-14 |
| Norges Bank | ▼ Sell | 5,496,133 | 0.87% | $465.47M | 2026-08-12 |
| AllianceBernstein L.P. | ▼ Sell | 4,439,611 | 0.70% | $371.64M | 2026-08-14 |
| AQR Capital Management LLC | ▼ Sell | 2,121,405 | 0.33% | $177.22M | 2026-08-14 |
| Balyasny Asset Management L.P. | ▲ Buy | 1,804,482 | 0.28% | $152.82M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 1,448,712 | 0.23% | $122.69M | 2026-08-03 |
| Millennium Management LLC | ▲ Buy | 1,310,524 | 0.21% | $110.99M | 2026-08-14 |
| Neuberger Berman Group LLC | ▼ Sell | 1,250,408 | 0.20% | $105.90M | 2026-08-13 |
| Wells Fargo & Company | ▼ Sell | 1,204,805 | 0.19% | $102.03M | 2026-08-14 |
| Citadel Advisors LLC | • Hold | 1,037,925 | 0.16% | $87.90M | 2026-09-02 |
| Adage Capital Partners GP, L.L.C. | ▼ Sell | 756,037 | 0.12% | $64.03M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 590,689 | 0.09% | $50.03M | 2026-08-14 |
Q2 2026 flow:24.35M sh bought ($2.06B)13.25M sh sold ($1.12B)net +11.10M sh (+$940.52M)
Congressional Trading Activity
3 disclosed trades · ~$48.5K est. traded value · 1 buys, 2 sells
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Gary Peters | Senate | MI | ▼ Sell | $15K - $50K | 2026-04-23 | 2026-05-11 |
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2024-10-29 | 2026-08-05 |